Mini Review
Published on 23 Jan 2023
Pharmacogenomics and health disparities, are we helping?
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2023.1099541
- 4,584 views
- 6 citations
Type at least 3 characters
137 articles
Original Research
Published on 16 Jan 2023
Addressing disparities in pharmacogenomics through rural and underserved workforce education
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1082985
- 2,220 views
- 5 citations
Original Research
Published on 13 Jan 2023
Exploring perceptions, knowledge, and attitudes regarding pharmacogenetic testing in the medically underserved
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1085994
- 3,857 views
- 9 citations
Mini Review
Published on 04 Jan 2023
Pharmacogenomic variabilities in geo-ancestral subpopulations and their clinical implications: Results of collaborations with Hmong in the United States
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1070236
- 2,236 views
- 5 citations
Original Research
Published on 04 Jan 2023
The impact of violating the independence assumption in meta-analysis on biomarker discovery
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1027345
- 2,868 views
- 4 citations
Original Research
Published on 30 Nov 2022
Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1028081
- 5,202 views
- 17 citations
Review
Published on 11 Nov 2022
Polygenic risk scores: An overview from bench to bedside for personalised medicine
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1000667
- 11,132 views
- 47 citations
Original Research
Published on 13 Oct 2022
Allelic diversity of the pharmacogene CYP2D6 in New Zealand Māori and Pacific peoples
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1016416
- 4,391 views
- 6 citations
Original Research
Published on 14 Sep 2022
Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.982955
- 4,510 views
- 12 citations
Original Research
Published on 06 Sep 2022
Genome-wide identification of alternative splicing associated with histone deacetylase inhibitor in cutaneous T-cell lymphomas
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.937623
- 2,300 views
- 1 citation
Original Research
Published on 25 Aug 2022
Comprehensive characterization of pharmacogenes in a Taiwanese Han population
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.948616
- 3,193 views
- 7 citations
Systematic Review
Published on 16 Aug 2022
Systematic review of gastric cancer-associated genetic variants, gene-based meta-analysis, and gene-level functional analysis to identify candidate genes for drug development
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.928783
- 5,880 views
- 9 citations
Review
Published on 08 Aug 2022
Drosophila melanogaster: A platform for anticancer drug discovery and personalized therapies
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.949241
- 15,065 views
- 29 citations
Original Research
Published on 18 Jul 2022
Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema Genes
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.914376
- 4,207 views
- 8 citations
Mini Review
Published on 11 Jul 2022
Susceptibility Genes and HLA for Cold Medicine-Related SJS/TEN with SOC
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.912478
- 2,695 views
- 4 citations
Review
Published on 08 Jul 2022
Insights Into the Role of Epigenetic Factors Determining the Estrogen Response in Estrogen-Positive Ovarian Cancer and Prospects of Combining Epi-Drugs With Endocrine Therapy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.812077
- 3,832 views
- 7 citations